Nanoparticle-mediated delivery of siRNA targeting Parpi extends survival of mice bearing tumors derived from Breal-deficient ovarian cancer cells

著录项

• 来源
  《Proceedings of the National Academy of Sciences of the United States of America》 |2011年第2期|p.745-750|共6页
• 作者

  Michael S. Goldberg; Deyin Xing; Yin Ren; Sandra Orsulic; Sangeeta N. Bhatia; Phillip A. Sharp;

  展开▼
• 作者单位

  David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;

  David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139;

  Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139;

  Women's Cancer Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048;

  David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139,Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139;

  David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139,Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139;

  展开▼
• 收录信息 美国《科学引文索引》(SCI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
• 原文格式 PDF
• 正文语种 eng
• 中图分类
• 关键词

  drug delivery; RNAi;

  机译：药物输送;RNA干扰;